Seventeen piglets were infected with a continuous intravenous infusion of live group B β-hemolytic streptococci (GBS). Hemodynamic changes were recorded, and blood samples were drawn for measurement of thromboxane B2 (TxB2) (stable metabolite of thromboxane A2) and 6-keto-PGE(1α) (stable metabolite of prostacyclin). Control animals (n = 9) received only bacteria, while treatment animals (n = 8) received indomethacin, 3 mg/kg IV, 15 min after the start of the bacterial infusion. Control animals responded to the bacteria within 15 min with marked elevation in mean pulmonary artery pressure (Ppa) from 15 ± 8 to 39 ± 6 mm Hg and decline in PaO2 from 80 ± 11 to 51 ± 6 mm Hg and cardiac output (CO) from 0.24 ± 0.07 to 0.13 ± 0.07 liters/min/kg. Mean arterial blood pressure (AoP) significantly decreased from baseline value of 95 ± 13 to 51 ± 32 mm Hg by 180 min. In animals treated with indomethacin, these changes were reversed or significantly attenuated. The hemodynamic changes were associated temporally with elevations in plasma concentrations of TxB2 or 6-keto-PGF(1α). In the first 60 min, TxB2 levels in both groups correlated with Ppa (r = 0.72, p < 0.001) and PaO2 (r = -0.60, p < 0.001). A strong negative correlation between TxB2 and CO was observed over the first 180 min (r = -0.73, p < 0.001). There was statistically significant correlation between AoP and 6-keto-PGF(1α) concentration between 60 and 180 min (r = -0.54, p < 0.002). Indomethacin improved the hemodynamic function in this model of GBS sepsis. This improvement was related in part to inhibition of synthesis of thromboxane A2 and prostacyclin.
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health